Zobrazeno 1 - 10
of 43
pro vyhledávání: '"Doris R Siwak"'
Autor:
Noriyuki Sasaki, Takeshi Iwaya, Takehiro Chiba, Masashi Fujita, Zhenlin Ju, Fumitaka Endo, Mizunori Yaegashi, Tsuyoshi Hachiya, Ryo Sugimoto, Tamotsu Sugai, Doris R Siwak, Lance A Liotta, Yiling Lu, Gordon B Mills, Hidewaki Nakagawa, Satoshi S Nishizuka
Publikováno v:
PLoS ONE, Vol 15, Iss 10, p e0239966 (2020)
Circulating tumor DNA (ctDNA) is released from tumor cells into blood in advanced cancer patients. Although gene mutations in individual tumors can be diverse and heterogenous, ctDNA has the potential to provide comprehensive biomarker information. H
Externí odkaz:
https://doaj.org/article/3d3ac3aee9d64e55b0d52d0eec6c446f
Autor:
Mary E Irwin, Laura D Nelson, Janice M Santiago-O'Farrill, Phillip D Knouse, Claudia P Miller, Shana L Palla, Doris R Siwak, Gordon B Mills, Zeev Estrov, Shulin Li, Steven M Kornblau, Dennis P Hughes, Joya Chandra
Publikováno v:
PLoS ONE, Vol 8, Iss 8, p e70608 (2013)
The presence of the Philadelphia chromosome in patients with acute lymphoblastic leukemia (Ph(+)ALL) is a negative prognostic indicator. Tyrosine kinase inhibitors (TKI) that target BCR/ABL, such as imatinib, have improved treatment of Ph(+)ALL and a
Externí odkaz:
https://doaj.org/article/19d8ea1ce2de45fdacb0e53373ec405d
Autor:
Ann Marie Egloff, Jennifer R. Grandis, Jill M. Siegfried, Athanassios Argiris, Gordon B. Mills, Corwin Joy, Carol Sherer, Kathleen Cieply, Lin Wang, Raja R. Seethala, Courtney LaValle, Raymond Chai, Doris R. Siwak, Sarah Wheeler
Purpose: To assess the prognostic value of epidermal growth factor receptor (EGFR) molecular characteristics of head and neck squamous cell carcinoma (HNSCC).Patients and Methods: HNSCC tumors from patients prospectively enrolled in either an Early D
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::58282b89d2f042e93403fea97e8ff9ca
https://doi.org/10.1158/1078-0432.c.6520193
https://doi.org/10.1158/1078-0432.c.6520193
Autor:
Heike Allgayer, Christian Manegold, Lothar R. Pilz, Erika Buchholz, Andrea Harms, Gordon B. Mills, Doris R. Siwak, Dennis P.M. Hughes, Laura D. Nelson, Irfan A. Asangani, Dessislava A. Nikolova
Supplementary Figure 2 from Cetuximab Attenuates Metastasis and u-PAR Expression in Non–Small Cell Lung Cancer: u-PAR and E-Cadherin are Novel Biomarkers of Cetuximab Sensitivity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::4d422492a2731f93dd9d5959a015dbae
https://doi.org/10.1158/0008-5472.22379933.v1
https://doi.org/10.1158/0008-5472.22379933.v1
Autor:
Heike Allgayer, Christian Manegold, Lothar R. Pilz, Erika Buchholz, Andrea Harms, Gordon B. Mills, Doris R. Siwak, Dennis P.M. Hughes, Laura D. Nelson, Irfan A. Asangani, Dessislava A. Nikolova
Supplementary Figure 3 from Cetuximab Attenuates Metastasis and u-PAR Expression in Non–Small Cell Lung Cancer: u-PAR and E-Cadherin are Novel Biomarkers of Cetuximab Sensitivity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35e23764df5033000449b4c1e174987c
https://doi.org/10.1158/0008-5472.22379930.v1
https://doi.org/10.1158/0008-5472.22379930.v1
Autor:
Heike Allgayer, Christian Manegold, Lothar R. Pilz, Erika Buchholz, Andrea Harms, Gordon B. Mills, Doris R. Siwak, Dennis P.M. Hughes, Laura D. Nelson, Irfan A. Asangani, Dessislava A. Nikolova
Supplementary Figure 1 from Cetuximab Attenuates Metastasis and u-PAR Expression in Non–Small Cell Lung Cancer: u-PAR and E-Cadherin are Novel Biomarkers of Cetuximab Sensitivity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f5a14f0d616fc0fb3356f38aa6539e1
https://doi.org/10.1158/0008-5472.22379936
https://doi.org/10.1158/0008-5472.22379936
Autor:
Heike Allgayer, Christian Manegold, Lothar R. Pilz, Erika Buchholz, Andrea Harms, Gordon B. Mills, Doris R. Siwak, Dennis P.M. Hughes, Laura D. Nelson, Irfan A. Asangani, Dessislava A. Nikolova
Cetuximab, which blocks ligand binding to epidermal growth factor receptor (EGFR), is currently being studied as a novel treatment for non–small cell lung cancer (NSCLC). However, its mechanisms of action toward metastasis, and markers of drug sens
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::12ad319933f44db603eb364c29c9b788
https://doi.org/10.1158/0008-5472.c.6499400.v1
https://doi.org/10.1158/0008-5472.c.6499400.v1
Autor:
Heike Allgayer, Christian Manegold, Lothar R. Pilz, Erika Buchholz, Andrea Harms, Gordon B. Mills, Doris R. Siwak, Dennis P.M. Hughes, Laura D. Nelson, Irfan A. Asangani, Dessislava A. Nikolova
Supplementary Figure 4 from Cetuximab Attenuates Metastasis and u-PAR Expression in Non–Small Cell Lung Cancer: u-PAR and E-Cadherin are Novel Biomarkers of Cetuximab Sensitivity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7ea22578f404c134c7a2d6bd1753bc15
https://doi.org/10.1158/0008-5472.22379927.v1
https://doi.org/10.1158/0008-5472.22379927.v1
Autor:
Heike Allgayer, Christian Manegold, Lothar R. Pilz, Erika Buchholz, Andrea Harms, Gordon B. Mills, Doris R. Siwak, Dennis P.M. Hughes, Laura D. Nelson, Irfan A. Asangani, Dessislava A. Nikolova
Supplementary Figure 5 from Cetuximab Attenuates Metastasis and u-PAR Expression in Non–Small Cell Lung Cancer: u-PAR and E-Cadherin are Novel Biomarkers of Cetuximab Sensitivity
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::998495c4d6cb48785e1fa9cd062b4ff6
https://doi.org/10.1158/0008-5472.22379924
https://doi.org/10.1158/0008-5472.22379924
Autor:
Huma Shehwana, Shwetha V Kumar, James M Melott, Mary A Rohrdanz, Chris Wakefield, Zhenlin Ju, Doris R Siwak, Yiling Lu, Bradley M Broom, John N Weinstein, Gordon B Mills, Rehan Akbani
Publikováno v:
Bioinformatics. 38:5131-5133
Summary Reverse-Phase Protein Array (RPPA) is a robust high-throughput, cost-effective platform for quantitatively measuring proteins in biological specimens. However, converting raw RPPA data into normalized, analysis-ready data remains a challengin